Data / Form D filings / ALZHEON, INC.
ALZHEON, INC.: Form D filings
ALZHEON, INC., a biotechnology company in Framingham, MA, filed 15 Form D notices with the SEC between 2013 and 2026. The latest, on September 10, 2026, reports $78.8 million sold of a $500 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 111 SPEEN STREET SUITE 306, Framingham, MA, 01701
- Phone
- (508) 861-7709
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1582636
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | New notice | $499,999,999 | $78,797,184 | $421,202,815 | 3 | Aug 26, 2026 | sec.gov |
| Feb 10, 2025 | Amendment | $150,000,000 | $126,259,938 | $23,740,062 | 76 | Feb 27, 2024 | sec.gov |
| Jan 2, 2025 | Amendment | $125,000,031 | $125,000,031 | 76 | Feb 27, 2024 | sec.gov | |
| Mar 12, 2024 | New notice | $49,995,798 | $17,249,891 | $32,745,907 | 2 | Feb 27, 2024 | sec.gov |
| Jan 11, 2023 | New notice | $50,004,201 | $1,703,768 | $48,300,433 | 6 | Dec 27, 2022 | sec.gov |
| Sep 30, 2020 | New notice | $50,000,004 | $2,432,016 | $47,567,988 | 5 | Sep 16, 2020 | sec.gov |
| Jan 15, 2020 | New notice | $6,163,716 | $6,163,716 | 13 | Apr 25, 2019 | sec.gov | |
| Sep 5, 2018 | Amendment | $19,801,820 | $19,801,820 | 81 | May 25, 2017 | sec.gov | |
| Jun 9, 2017 | New notice | $15,764,099 | $15,764,099 | 63 | May 25, 2017 | sec.gov | |
| Feb 26, 2016 | New notice | $5,000,000 | $1,300,000 | $3,700,000 | 3 | Feb 4, 2016 | sec.gov |
| Jul 27, 2015 | New notice | $6,905,000 | $6,905,000 | 26 | Jul 13, 2015 | sec.gov | |
| Feb 25, 2015 | Amendment | Indefinite | $7,344,629 | 60 | Dec 30, 2014 | sec.gov | |
| Jan 9, 2015 | New notice | Indefinite | $3,050,000 | 12 | Dec 30, 2014 | sec.gov | |
| Dec 16, 2013 | Amendment | $550,000 | $550,000 | 8 | Jul 23, 2013 | sec.gov | |
| Jul 31, 2013 | New notice | $550,000 | $330,000 | $220,000 | 8 | Jul 23, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Tolar, M.D., Ph.D. | Executive Officer, Director | President and Chief Executive Officer |
| Christopher Noel Dunn | Director | |
| Neil W. Flanzraich | Director | |
| Jordan Heller | Director | |
| Diane K. Jorkasky, M.D. | Director | |
| Gino Santini | Director | |
| Muneer Satter | Director | |
| Kenneth Mace | Executive Officer | Treasurer and Chief Financial Officer |
| Susan Abushakra, M.D. | Executive Officer | Chief Medical Officer |
| John Hey, Ph.D. | Executive Officer | Chief Scientific Officer |
| Aidan Power, MRCPsych | Executive Officer | Chief Development Officer |
| Adem Albayrak | Executive Officer | Chief Data Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 7, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ALZHEON, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.